Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › H2020

OACTIVE · Advanced personalised, multi-scale computer models preventing OsteoArthritis

H2020Status: CLOSED1 November 201730 April 2021EU funding €4,984,034Call H2020-SC1-2016-2017

Osteoarthritis (OA) is a degenerative disease of the articular cartilage and the most common form of arthritis that causes joint pain, mobility limitation and, thus, reduces independence and overall quality of life. Although the usual population associated with the condition is the elderly (65 years old ranges from 12- 30%), who are mostly inactive, athletes and younger individuals are also susceptible. Whilst the available data have implicated the role of the various modifiable or non-modifiable risk factors in the development and progression of OA, no study has conclusively explored the interaction and integration of other information sets in a patient-specific manner. The current OACTIVE project intents to make a significant leap forward adopting a multi-scale holistic approach where patient-specific information from various levels, including cell, tissue, organ and whole body will be integrated and combined with information from other sources such as biochemical/inflammatory biomarkers, behaviour modeling and social/environmental risk factors to generate robust predictors for new personalised interventions for delaying onset and slowing down progression of OA. OACTIVE targets to patient-specific OA prediction and interventions by using a combination of mechanistic, phenomenological computational models, simulations and big data analytics. Once constructed, these models will be used to simulate and predict optimal treatments, better diagnostics, and improved patient outcomes. Overcoming the limitation of the current treatment interventions, Augmented Reality empowered interventions will be developed in a personalised framework allowing patients experience the treatment as more enjoyable, resulting in greater motivation, engagement, and training adherence. OACTIVE’s mission is to improve healthcare by transforming and accelerating the OA diagnosis and prediction based on a more comprehensive understanding of disease pathophysiology, dynamics, and patient outcomes.

Consortium · 13 organisations

coordinator

EDEX - EDUCATIONAL EXCELLENCE CORPORATION LIMITED

CY · €521,000

participant

TIMELEX

BE · €186,750

participant

ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS

EL · €506,875

participant

CENTER FOR TECHNOLOGY RESEARCH ANDINNOVATION (CETRI) LTD

CY · €477,000

participant

LIVERPOOL JOHN MOORES UNIVERSITY

UK · €444,721

participant

AXIA INNOVATION GmbH

DE · €248,750

participant

FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA

ES · €317,250

participant

ANIMUS KENTRO APOTHERAPEIAS KAI APOKATASTASIS ANONYMI ETAIRIA

EL · €218,750

participant

ACONDICIONAMIENTO TARRASENSE ASSOCIACION

ES · €422,500

participant

SMARTEX SRL

IT · €456,063

participant

KATHOLIEKE UNIVERSITEIT LEUVEN

BE · €354,063

participant

FONDAZIONE RI.MED

IT · €399,063

participant

PANEPISTIMIO PATRON

EL · €431,250

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.